beta-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))

Term ID

CHEBI:142994

Synonyms

beta-D-Gal-(1->3)-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->3)-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer(d18:1(4E))
beta-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-N-acylsphing-4E-enine
beta-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-N-acylsphingosine
IV(3)-b-(Gal-b1-3GlcNAc)-Lc4Cer(d18:1(4E))
Lc6Cer(d18:1(4E))

Definition

References

Ontology

ChEBI ( EBI )

Relationships

is a type of: beta-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide organic molecular entity

beta-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide organic molecular entity Show first 5 Terms

Phenotype

Phenotype resulting from beta-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))

Phenotype where environments contain beta-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))

Phenotype modified by environments containing beta-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))

Human Disease Model